Phio Pharmaceuticals Corp (PHIO)

[sabaidii2]

"I think our frustrations will be rewarded in due time."

In due time?! Are you joking?
The ophthalmology pipeline is way, way off in the future, while RXI is facing its now-standard financial drop-dead date.

That kind of long-view "visionary / pollyanish" type of "investing" is a wonderful way to lose money.

I suspect the dermal scarring pipeline has yet more Phase 2 testing in its future (specifically, Phase 2B).

The reality is that the nearer term Samcyprone and cosmeceutical pipelines had better not run into problems (so far, so good). Samcyprone seems to be getting better than expected results.
And IF the cosmeceuticals work as touted (which we'll soon see), the share price will explode.